These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 21272812)
1. Rapid onset of ulcerative colitis after treatment with interferon β1a in a patient with multiple sclerosis. Tuna Y; Başar O; Dikici H; Köklü S J Crohns Colitis; 2011 Feb; 5(1):75-6. PubMed ID: 21272812 [No Abstract] [Full Text] [Related]
2. Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a. Schott E; Paul F; Wuerfel JT; Zipp F; Rudolph B; Wiedenmann B; Baumgart DC World J Gastroenterol; 2007 Jul; 13(26):3638-40. PubMed ID: 17659718 [TBL] [Abstract][Full Text] [Related]
4. New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson. Alsalameh S; Manger B; Kern P; Kalden J Arthritis Rheum; 1998 Apr; 41(4):754. PubMed ID: 9550494 [No Abstract] [Full Text] [Related]
5. Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a. Rodrigues S; Magro F; Soares J; Nunes AC; Lopes S; Marques M; Rio E; Macedo G Inflamm Bowel Dis; 2010 Dec; 16(12):2001-3. PubMed ID: 20186933 [No Abstract] [Full Text] [Related]
6. Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a. Tola MR; Caniatti LM; Gragnaniello D; Russo M; Stabellini N; Granieri E J Neurol; 2003 Jun; 250(6):768-9. PubMed ID: 12862038 [No Abstract] [Full Text] [Related]
7. Acute hepatitis secondary to interferon beta-1a in multiple sclerosis. Christopher V; Scolding N; Przemioslo RT J Neurol; 2005 Jul; 252(7):855-6. PubMed ID: 15742101 [No Abstract] [Full Text] [Related]
18. Interferon beta-1a and beta-1b for treatment of multiple sclerosis. Kappos L Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424020 [No Abstract] [Full Text] [Related]
19. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report. Kocer B; Nazliel B; Oztas M; Batur HZ Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549 [No Abstract] [Full Text] [Related]
20. [Possibilities and limits of immunotherapy in multiple sclerosis. Inflammatory and degenerative aspects of the disease require a new pathogenetic concept]. Kornhuber ME; Zierz S Nervenarzt; 2003 Jun; 74(6):537-8; discussion 539. PubMed ID: 12799792 [No Abstract] [Full Text] [Related] [Next] [New Search]